Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis
Phase 3
Completed
- Conditions
- Primary Biliary Cirrhosis
- Interventions
- Other: PlaceboDrug: Tetrathiomolybdate
- First Posted Date
- 2008-12-10
- Last Posted Date
- 2017-05-23
- Lead Sponsor
- George Brewer
- Target Recruit Count
- 29
- Registration Number
- NCT00805805
- Locations
- 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
© Copyright 2025. All Rights Reserved by MedPath